Use of the lipoxin receptor, FPRL1, as a tool for identifying compounds effective in the treatment of pain and inflammation

Details for Australian Patent Application No. 2004290368 (hide)

Owner Acadia Pharmaceuticals Inc.

Inventors Scully, Audra L.; Gardell, Luis; Gustafsson, Magnus; Nash, Norman; Olsson, Roger

Agent FB Rice

Pub. Number AU-A-2004290368

PCT Pub. Number WO2005/047899

Priority 60/592,926 30.07.04 US; 60/518,476 07.11.03 US; 60/519,085 10.11.03 US

Filing date 4 November 2004

Wipo publication date 26 May 2005

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/047899 Priority application(s): WO2005/047899

16 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290369-Method of preparing nucleic acids for detection

2004290359-System and method for evaluating underwriting requirements